Craig Bijou
Stock Analyst at B of A Securities
(1.62)
# 2,330
Out of 4,667 analysts
57
Total ratings
50%
Success rate
21.55%
Average return
Main Sectors:
Stocks Rated by Craig Bijou
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMED Globus Medical | Maintains: Underperform | $55 → $80 | $83.59 | -4.29% | 3 | Nov 6, 2024 | |
| IART Integra LifeSciences Holdings | Maintains: Underperform | $26 → $18 | $22.93 | -21.50% | 13 | Oct 7, 2024 | |
| ITGR Integer Holdings | Maintains: Buy | $135 → $145 | $133.37 | +8.72% | 3 | Oct 1, 2024 | |
| MMSI Merit Medical Systems | Maintains: Neutral | $92 → $103 | $104.08 | -1.04% | 3 | Sep 16, 2024 | |
| HAE Haemonetics | Initiates: Neutral | $85 | $84.92 | +0.09% | 1 | Sep 11, 2024 | |
| PRCT PROCEPT BioRobotics | Maintains: Buy | $80 → $94 | $92.70 | +1.40% | 3 | Aug 22, 2024 | |
| GEHC GE HealthCare Technologies | Maintains: Neutral | $94 → $86 | $84.90 | +1.30% | 2 | May 1, 2024 | |
| COO The Cooper Companies | Initiates: Buy | $95 | $99.08 | -4.12% | 1 | Oct 30, 2023 | |
| TFX Teleflex | Maintains: Neutral | $265 | $187.43 | +41.39% | 4 | Aug 3, 2023 | |
| BLCO Bausch + Lomb | Maintains: Buy | $19 → $23 | $19.38 | +18.68% | 1 | Jul 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $25 | $10.35 | +141.55% | 1 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $36 | $12.15 | +196.30% | 2 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $23 → $45 | $8.06 | +458.31% | 3 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $1 → $8 | $0.72 | +1,012.66% | 2 | Mar 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $9.94 | +201.81% | 5 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $17 → $13 | $9.83 | +32.25% | 2 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $48 → $42 | $18.87 | +122.58% | 3 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $207 → $230 | $541.82 | -57.55% | 1 | Jan 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $190 → $230 | $385.68 | -40.37% | 4 | Jul 26, 2019 |
Globus Medical
Nov 6, 2024
Maintains: Underperform
Price Target: $55 → $80
Current: $83.59
Upside: -4.29%
Integra LifeSciences Holdings
Oct 7, 2024
Maintains: Underperform
Price Target: $26 → $18
Current: $22.93
Upside: -21.50%
Integer Holdings
Oct 1, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $133.37
Upside: +8.72%
Merit Medical Systems
Sep 16, 2024
Maintains: Neutral
Price Target: $92 → $103
Current: $104.08
Upside: -1.04%
Haemonetics
Sep 11, 2024
Initiates: Neutral
Price Target: $85
Current: $84.92
Upside: +0.09%
PROCEPT BioRobotics
Aug 22, 2024
Maintains: Buy
Price Target: $80 → $94
Current: $92.70
Upside: +1.40%
GE HealthCare Technologies
May 1, 2024
Maintains: Neutral
Price Target: $94 → $86
Current: $84.90
Upside: +1.30%
The Cooper Companies
Oct 30, 2023
Initiates: Buy
Price Target: $95
Current: $99.08
Upside: -4.12%
Teleflex
Aug 3, 2023
Maintains: Neutral
Price Target: $265
Current: $187.43
Upside: +41.39%
Bausch + Lomb
Jul 3, 2023
Maintains: Buy
Price Target: $19 → $23
Current: $19.38
Upside: +18.68%
Mar 9, 2022
Maintains: Buy
Price Target: $30 → $25
Current: $10.35
Upside: +141.55%
Jan 18, 2022
Maintains: Buy
Price Target: $43 → $36
Current: $12.15
Upside: +196.30%
May 13, 2020
Reiterates: Overweight
Price Target: $23 → $45
Current: $8.06
Upside: +458.31%
Mar 25, 2020
Maintains: Overweight
Price Target: $1 → $8
Current: $0.72
Upside: +1,012.66%
Mar 24, 2020
Maintains: Neutral
Price Target: $60 → $30
Current: $9.94
Upside: +201.81%
Mar 24, 2020
Reiterates: Overweight
Price Target: $17 → $13
Current: $9.83
Upside: +32.25%
Feb 25, 2020
Maintains: Neutral
Price Target: $48 → $42
Current: $18.87
Upside: +122.58%
Jan 10, 2020
Reiterates: Overweight
Price Target: $207 → $230
Current: $541.82
Upside: -57.55%
Jul 26, 2019
Maintains: Neutral
Price Target: $190 → $230
Current: $385.68
Upside: -40.37%